The Cancer Therapy Strategy VERAXA Is Betting the Company On
By Karen Roman VERAXA Biotech AG (Nasdaq: VRXA) said it expects BiTAC molecules to be...
Editorial
VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone
By Karen Roman VERAXA Biotech AG (Nasdaq: VRXA) said it started cell line development for...
SkylineDx’s Merlin CP-GEP Granted FDA Breakthrough Device Designation
By Karen Roman SkylineDx said the FDA granted Breakthrough Device Designation to Merlin CP-GEP, the...
Imviva Biotech Granted FDA IDE Authorization for Cancer Treatment Trial
By Karen Roman Imviva Biotech said it has FDA authorization for its Investigational Device Exemption...
Tackling the AI Security Crisis: Pax8’s Rob Belgrave and SentinelOne’s Steve Stone, Live from Pax8 Beyond 2026
Tech Edge hosted a fireside chat on June 9 at Pax8 Beyond 2026 in Salt...
Human-led Management of Autonomous Digital Workers: Pax8 Global Sr Director Renee McCloden, Halo CCO Tim Barton-Wines, Live from Pax8 Beyond 2026
Watch Video Highlights Below, or Click HERE: Tech Edge hosted a fireside chat on June...
The AI Race Has Changed: How MSPs Drive Growth for SMBs: Pax8 CSO Ryan Walsh, possibl.ai CEO Nyssa Waters, Live from Pax8 Beyond 2026
Watch Video Highlights Below, or Click HERE: Tech Edge hosted a fireside chat on June...
Candel Therapeutics Designates Mark Sims as CCO
By Karen Roman Candel Therapeutics, Inc. (Nasdaq: CADL) said it appointed Mark Sims as Chief...
Tech’s Multi-Trillion-Dollar Opportunity: Pax8 CFO Craig Foster, Live from Pax8 Beyond 2026
Watch Video Highlights Below, or Click HERE: Tech Edge hosted a fireside chat on June...
Small Business Driving AI’s Next Boom: Pax8’s Ryan Walsh and Jen Bodell, Live from Pax8 Beyond 2026
Watch Video Highlights Below, or Click HERE: Tech Edge hosted a fireside chat on June...
© Copyright 2025, ExecEdge